Medroxyprogesterone
CHEBI:CHEBI_6715
Definition
A 3-oxo Delta(4)-steroid that is pregn-4-ene-3,20-dione substituted by an alpha-hydroxy group at position 17 and a methyl group at position 6.
Chemical Information
- Molecular Formula
- C22H32O3
- Molecular Mass
- 344.495
- Charge
- 0
- SMILES
- C1[C@]2([C@]3([C@@]([C@@]4(C(=CC(CC4)=O)[C@H](C3)C)C)(CC[C@@]2([C@@](C1)(O)C(=O)C)C)[H])[H])[H]
- InChI
- InChI=1S/C22H32O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h12-13,16-18,25H,5-11H2,1-4H3/t13-,16+,17-,18-,20+,21-,22-/m0/s1
- InChIKey
- FRQMUZJSZHZSGN-HBNHAYAOSA-N
Alternative Names
- (6alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione
- 17-Hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione
- 17-Hydroxy-6alpha-methylprogesterone
- 17alpha-Hydroxy-6alpha-methylprogesterone
- 6alpha-Methyl-17alpha-hydroxyprogesterone
- 6alpha-Methyl-4-pregnen-17alpha-ol-3,20-dione
- medroxiprogesterona
- Medroxyprogesteron
- medroxyprogesterone
- medroxyprogesteronum
Drug Classification
-
20-oxo steroidView Class →
CHEBI:36885
-
tertiary alpha-hydroxy ketoneView Class →
CHEBI:139592
-
17alpha-hydroxy steroidView Class →
CHEBI:35342
-
3-oxo-Delta(4) steroidView Class →
CHEBI:47909
-
t268640
-
t269092
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 6691
- oboInOwl#hasDbXref
- Reaxys:2510965
- core#notation
- CHEBI:6715
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- package_description
- 1000 g in 1 DRUM (46439-8749-6)
- package_ndc
- 63592-0089-2
- package_marketing_start_date
- 19921029
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- dosage_form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- labeler_name
- Hikma Pharmaceuticals USA inc.
- marketing_start_date
- 19921029
- application_number
- ANDA210760
- product_ndc
- 0009-0051
- rxcui
- 1000158
- manufacturer_name
- Hikma Pharmaceuticals USA inc.
- active_ingredient_strength
- 104 mg/.65mL
- active_ingredient_name
- MEDROXYPROGESTERONE ACETATE
- unii
- C2QI4IOI2G
- spl_set_id
- d1ea4098-6196-421f-b8e1-bcb31a061e04
- upc
- 0368071413236
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 6691
- oboInOwl#hasDbXref
- Reaxys:2510965
- oboInOwl#id
- CHEBI:6715
- generic_name
- medroxyprogesterone acetate
- brand_name
- Depo-Provera
- brand_name_base
- Depo-Provera
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_49326
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- listing_expiration_date
- 20241231
- route
- SUBCUTANEOUS
- spl_id
- 6c3226aa-3059-4127-8428-77c243716b4f
- core#notation
- CHEBI:6715
- pharm_class
- Progesterone Congeners [CS]
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- has_treatment
- http://purl.obolibrary.org/obo/DOID_1618
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect31681
- owl#annotatedSource
- t269851
- owl#someValuesFrom
- t2910124